Logo image of EB

EVENTBRITE INC-CLASS A (EB) Stock Fundamental Analysis

NYSE:EB - New York Stock Exchange, Inc. - US29975E1091 - Common Stock - Currency: USD

3.25  -0.12 (-3.56%)

After market: 3.25 0 (0%)

Fundamental Rating

2

Taking everything into account, EB scores 2 out of 10 in our fundamental rating. EB was compared to 71 industry peers in the Entertainment industry. EB has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, EB is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year EB has reported negative net income.
In the past year EB had a positive cash flow from operations.
In the past 5 years EB always reported negative net income.
EB had a positive operating cash flow in 4 of the past 5 years.
EB Yearly Net Income VS EBIT VS OCF VS FCFEB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 -100M -200M

1.2 Ratios

Looking at the Return On Assets, with a value of -0.99%, EB is in line with its industry, outperforming 59.09% of the companies in the same industry.
Looking at the Return On Equity, with a value of -4.52%, EB is in the better half of the industry, outperforming 60.61% of the companies in the same industry.
Industry RankSector Rank
ROA -0.99%
ROE -4.52%
ROIC N/A
ROA(3y)-8.16%
ROA(5y)-12.25%
ROE(3y)-42.98%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A
EB Yearly ROA, ROE, ROICEB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 -20 -40 -60 -80

1.3 Margins

Looking at the Gross Margin, with a value of 70.22%, EB belongs to the top of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Gross Margin of EB has grown nicely.
EB does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 70.22%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.72%
GM growth 5Y3.3%
EB Yearly Profit, Operating, Gross MarginsEB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 -100 -150 -200

More info and screens

2

2. Health

2.1 Basic Checks

EB does not have a ROIC to compare to the WACC, probably because it is not profitable.
EB has more shares outstanding than it did 1 year ago.
The number of shares outstanding for EB has been increased compared to 5 years ago.
Compared to 1 year ago, EB has an improved debt to assets ratio.
EB Yearly Shares OutstandingEB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
EB Yearly Total Debt VS Total AssetsEB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M

2.2 Solvency

Based on the Altman-Z score of -0.48, we must say that EB is in the distress zone and has some risk of bankruptcy.
EB has a Altman-Z score of -0.48. This is in the lower half of the industry: EB underperforms 74.24% of its industry peers.
EB has a Debt/Equity ratio of 1.34. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.34, EB is doing worse than 71.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Altman-Z -0.48
ROIC/WACCN/A
WACC5.79%
EB Yearly LT Debt VS Equity VS FCFEB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 0 100M -100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 1.56 indicates that EB should not have too much problems paying its short term obligations.
EB's Current ratio of 1.56 is fine compared to the rest of the industry. EB outperforms 66.67% of its industry peers.
EB has a Quick Ratio of 1.56. This is a normal value and indicates that EB is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of EB (1.56) is better than 66.67% of its industry peers.
Industry RankSector Rank
Current Ratio 1.56
Quick Ratio 1.56
EB Yearly Current Assets VS Current LiabilitesEB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

More info and screens

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 59.09% over the past year.
The Revenue has grown by 8.54% in the past year. This is quite good.
The Revenue has been growing slightly by 2.26% on average over the past years.
EPS 1Y (TTM)59.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
Revenue 1Y (TTM)8.54%
Revenue growth 3Y45.44%
Revenue growth 5Y2.26%
Sales Q2Q%-4.59%

3.2 Future

The Earnings Per Share is expected to grow by 25.44% on average over the next years. This is a very strong growth
EB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.83% yearly.
EPS Next Y52.09%
EPS Next 2Y41.91%
EPS Next 3Y28.86%
EPS Next 5Y25.44%
Revenue Next Year-0.63%
Revenue Next 2Y1.71%
Revenue Next 3Y6.14%
Revenue Next 5Y6.83%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EB Yearly Revenue VS EstimatesEB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 100M 200M 300M 400M 500M
EB Yearly EPS VS EstimatesEB Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 -1 -2

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for EB. In the last year negative earnings were reported.
With a Price/Forward Earnings ratio of 876.48, EB can be considered very expensive at the moment.
EB's Price/Forward Earnings is on the same level as the industry average.
When comparing the Price/Forward Earnings ratio of EB to the average of the S&P500 Index (22.70), we can say EB is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 876.48
EB Price Earnings VS Forward Price EarningsEB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600 800

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
EB Per share dataEB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates EB does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as EB's earnings are expected to grow with 28.86% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.91%
EPS Next 3Y28.86%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for EB!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

EVENTBRITE INC-CLASS A

NYSE:EB (2/21/2025, 8:14:54 PM)

After market: 3.25 0 (0%)

3.25

-0.12 (-3.56%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)11-07 2024-11-07/amc
Earnings (Next)02-27 2025-02-27/amc
Inst Owners75.97%
Inst Owner Change-93.5%
Ins Owners5.02%
Ins Owner Change24.41%
Market Cap314.86M
Analysts77.14
Price Target5.16 (58.77%)
Short Float %4.39%
Short Ratio3.49
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)94.06%
Min EPS beat(2)69.74%
Max EPS beat(2)118.39%
EPS beat(4)3
Avg EPS beat(4)58.38%
Min EPS beat(4)-34.1%
Max EPS beat(4)118.39%
EPS beat(8)7
Avg EPS beat(8)57.9%
EPS beat(12)8
Avg EPS beat(12)30.44%
EPS beat(16)11
Avg EPS beat(16)26.35%
Revenue beat(2)0
Avg Revenue beat(2)-2.7%
Min Revenue beat(2)-5.02%
Max Revenue beat(2)-0.39%
Revenue beat(4)0
Avg Revenue beat(4)-2.77%
Min Revenue beat(4)-5.02%
Max Revenue beat(4)-0.39%
Revenue beat(8)1
Avg Revenue beat(8)-2.12%
Revenue beat(12)3
Avg Revenue beat(12)-0.58%
Revenue beat(16)5
Avg Revenue beat(16)0.6%
PT rev (1m)0%
PT rev (3m)-1.22%
EPS NQ rev (1m)-3.92%
EPS NQ rev (3m)25.17%
EPS NY rev (1m)0%
EPS NY rev (3m)44.55%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.01%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 876.48
P/S 0.94
P/FCF N/A
P/OCF 110.63
P/B 1.75
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.09
EYN/A
EPS(NY)0
Fwd EY0.11%
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)0.03
OCFY0.9%
SpS3.47
BVpS1.86
TBVpS-0.02
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.99%
ROE -4.52%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 70.22%
FCFM N/A
ROA(3y)-8.16%
ROA(5y)-12.25%
ROE(3y)-42.98%
ROE(5y)-43.26%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y18.72%
GM growth 5Y3.3%
F-Score7
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 1.34
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 59.27%
Cap/Sales 2.65%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.56
Quick Ratio 1.56
Altman-Z -0.48
F-Score7
WACC5.79%
ROIC/WACCN/A
Cap/Depr(3y)31.86%
Cap/Depr(5y)35.85%
Cap/Sales(3y)1.75%
Cap/Sales(5y)3.07%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)59.09%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%60%
EPS Next Y52.09%
EPS Next 2Y41.91%
EPS Next 3Y28.86%
EPS Next 5Y25.44%
Revenue 1Y (TTM)8.54%
Revenue growth 3Y45.44%
Revenue growth 5Y2.26%
Sales Q2Q%-4.59%
Revenue Next Year-0.63%
Revenue Next 2Y1.71%
Revenue Next 3Y6.14%
Revenue Next 5Y6.83%
EBIT growth 1Y32.56%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year189.46%
EBIT Next 3Y52.18%
EBIT Next 5Y29.52%
FCF growth 1Y-123.36%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-90.64%
OCF growth 3YN/A
OCF growth 5Y21.58%